{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:26:23Z","timestamp":1769239583468,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Nerve damage in leprosy patients leads to deformities and disabilities. Oral corticosteroids are given early to prevent permanent injury. We present a new approach to treat well-established nerve damage with local injection of corticosteroids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 60-year-old leprosy patient presented with right claw hand deformity secondary to right ulnar and median neuropathy. Monthly intraneural injection of corticosteroids resulted in improvement in sensory and motor function of his right hand over a 6-month period. Nerve conduction velocity testing documented the success of our therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We report the first case of successful nerve regeneration in neglected neuropathy secondary to leprosy after local injection of corticosteroids. Intraneural extra-fascicular injection of corticosteroids improved the sensory and motor nerve function in our patient with borderline leprosy regardless of the duration of nerve function loss.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1752-1947-2-381","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T07:13:43Z","timestamp":1228893223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intraneural injection of corticosteroids to treat nerve damage in leprosy: a case report and review of literature"],"prefix":"10.1186","volume":"2","author":[{"given":"Sherine G","family":"Nashed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek A","family":"Rageh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad S","family":"Attallah-Wasif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A","family":"Abd-Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,9]]},"reference":[{"issue":"3","key":"568_CR1","first-page":"1","volume":"77","author":"WHO","year":"2006","unstructured":"WHO: Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (2006\u20132010). Operational guidelines. Lepr Rev. 2006, 77 (3): 1-50.","journal-title":"Lepr Rev"},{"key":"568_CR2","first-page":"1","volume-title":"Rook's Textbook of Dermatology","author":"DNJ Lockwood","year":"2004","unstructured":"Lockwood DNJ: Leprosy. Rook's Textbook of Dermatology. Edited by: Burns DA, Breathnach SM, Cox NH, Griffiths CEM. 2004, Oxford: Blackwell Publishing, 2: 1-29. 7","edition":"7"},{"issue":"6","key":"568_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.clineuro.2005.03.007","volume":"107","author":"A Agrawal","year":"2005","unstructured":"Agrawal A, Pandit L, Dalal M, Shetty JP: Neurological manifestations of Hansen's disease and their management. Clin Neurol Neurosurg. 2005, 107 (6): 445-454. 10.1016\/j.clineuro.2005.03.007.","journal-title":"Clin Neurol Neurosurg"},{"key":"568_CR4","first-page":"140","volume":"70","author":"RP Croft","year":"1999","unstructured":"Croft RP, Richardus JH, Nicholls PG, Smith WC: Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study). Lepr Rev. 1999, 70: 140-159.","journal-title":"Lepr Rev"},{"issue":"4","key":"568_CR5","first-page":"576","volume":"51","author":"CB Charosky","year":"1953","unstructured":"Charosky CB, Gatti JC, Cardama JE: Neuropathies in Hansen's disease. Int J Lepr Other Mycobact Dis. 1953, 51 (4): 576-586.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"568_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/1523-1747.ep12381958","volume":"102","author":"RL Modlin","year":"1994","unstructured":"Modlin RL: Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol. 1994, 102: 828-832. 10.1111\/1523-1747.ep12381958.","journal-title":"J Invest Dermatol"},{"key":"568_CR7","first-page":"193","volume-title":"Leprosy","author":"CK Job","year":"1994","unstructured":"Job CK: Pathology of leprosy. Leprosy. Edited by: Hastings RC. 1994, Edinburgh: Churchill Livingstone, 193-234. 2","edition":"2"},{"key":"568_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/bmb\/ldl010","volume":"77\/78","author":"SL Walker","year":"2006","unstructured":"Walker SL, Lockwood DNJ: The clinical and immunological features of leprosy. Br Med Bull. 2006, 77\/78: 103-121. 10.1093\/bmb\/ldl010.","journal-title":"Br Med Bull"},{"key":"568_CR9","first-page":"190","volume":"65","author":"WH van Brakel","year":"1994","unstructured":"van Brakel WH, Khawas IB, Lucas SB: Reactions in leprosy: an epidemiological study of 386 patients in West Nepal. Lepr Rev. 1994, 65: 190-203.","journal-title":"Lepr Rev"},{"key":"568_CR10","first-page":"410","volume-title":"Leprosy in Theory and Practice","author":"RG Cochrane","year":"1964","unstructured":"Cochrane RG: Neuritis in leprosy. Leprosy in Theory and Practice. Edited by: Cochrane RG, Davey TF. 1964, Bristol: Wright, 410-417. 2","edition":"2"},{"key":"568_CR11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","volume":"74","author":"L Pocaterra","year":"2006","unstructured":"Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN: Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg. 2006, 74: 868-879.","journal-title":"Am J Trop Med Hyg"},{"key":"568_CR12","first-page":"270","volume":"67","author":"R Manandhar","year":"1999","unstructured":"Manandhar R, LeMaster JW, Roche PW: Risk factors for erythema nodosum leprosum. Int J Lepr Other Mycobact Dis. 1999, 67: 270-278.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"568_CR13","first-page":"104","volume":"67","author":"WH van Brakel","year":"1996","unstructured":"van Brakel WH, Khawas IB: Nerve function impairment in leprosy: a clinical and epidemiological study \u2013 Part 2. Results of steroid treatment. Lepr Rev. 1996, 67: 104-118.","journal-title":"Lepr Rev"},{"key":"568_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.47276\/lr.74.1.35","volume":"74","author":"RP Croft","year":"2003","unstructured":"Croft RP, Nicholls PG, Steyerberg EW, Richardus JH, Withington SG, Smith WC: A clinical prediction rule for nerve function impairment in leprosy patients \u2013 revisited after 5 years of follow-up. Lepr Rev. 2003, 74: 35-41.","journal-title":"Lepr Rev"},{"issue":"Suppl","key":"568_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/03009748809102977","volume":"76","author":"HE Rugstad","year":"1988","unstructured":"Rugstad HE: Antiinflammatory and immunoregulatory effects of glucocorticoids: Mode of action. Scand J Rheumatol. 1988, 76 (Suppl): 257-264. 10.3109\/03009748809102977.","journal-title":"Scand J Rheumatol"},{"key":"568_CR16","first-page":"30","volume-title":"Manual of Dermatologic Therapeutics: With Essentials of Diagnosis","author":"KA Arndt","year":"1995","unstructured":"Arndt KA: Manual of Dermatologic Therapeutics: With Essentials of Diagnosis. 1995, Lippincott, Williams and Wilkins, 30-5","edition":"5"},{"key":"568_CR17","first-page":"61","volume":"66","author":"AL Moreira","year":"1998","unstructured":"Moreira AL, Kaplan G, Villahermosa LG, Fajardo TJ, Abalos RM, Cellona RV, Balagon MV, Tan EV, Walsh GP: Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL. Int J Lepr Other Mycobact Dis. 1998, 66: 61-65.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"568_CR18","volume-title":"WHO Expert Committee on Leprosy \u2013 Fifth Report","author":"WHO","year":"1977","unstructured":"WHO: WHO Expert Committee on Leprosy \u2013 Fifth Report. 1977, Technical Report Series 607. Geneva: World Health Organization"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-2-381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-2-381\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-2-381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-2-381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T03:16:43Z","timestamp":1630466203000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-2-381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-2-381","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"23 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"381"}}